Real World Development: Increasing Value for Patients

More White Papers

Published 22 September 2011 | By Kinapse

The traditional drug development paradigm must change. We propose a fundamentally new approach which will create a win-win partnership between industry, academia, health authorities, health technology assessment (HTA)/health economic program (HEP) bodies and patients. We call this new approach “Real World Development” the underlying principle of which is to constantly assess the product in as close to post-marketing use as possible. Key components of this approach are the use of adaptive trial design and capitalisation of existing real world data sources. It enhances the evaluation of benefit/risk, enable earlier patient access to innovative medicines, and improve value for money.

As a registered user of PBR you can skip the majority of this form. Registration is FREE so register now or log in if you're already a member.

Fill In Details

Title* First Name* Last Name* Email* Confirm Email* Telephone* Reason for Download*

Job Title* Job Function* If other job function please specify Company* Country* Company Activity If other company activity please specify

Help us to better improve our communications by entering all or some of the additional fields below, then click 'Download White Paper' to be taken to the next page.

AddressLine1 AddressLine2 City County/State Zip

Fax Company Turnover Number of Employees Role In Purchasing

Complete a quick security check and confirm terms and conditions

This step helps prevent unfair use of automated programs.

Type both words separated by a space below*

I have read and accept the terms and conditions and privacy policy.

We'd like to keep you informed about relevant promotions, products and services, or if you would prefer not to receive these, uncheck this box.

If you would prefer not to hear from carefully selected third party companies uncheck this box

By clicking the 'download white paper' button you agree to pass your details as shown to the white paper advertiser. The enquirer also permits the advertiser to follow up the enquiry by phone or email. PBR is in no way responsible for further communication between parties.
Fields marked * are compulsory

Related Intelligence and Suppliers

White Papers

Performance Management in Medical Affairs Kinapse White Papers

Ideas About the Future of the Innovative Pharmaceutical Industry Kinapse White Papers

Big Pharma R&D – thinking big, acting small Kinapse White Papers

Earned Value Management, an approach for effectively managing pipeline value Kinapse White Papers

Latest Products

Kinapse Outsourcing Kinapse Outsourcing provides cost-effective writing and analytical services for business critical information and documents for reporting and submissions. Products

Production & Manufacturing Fine & Speciality Chemicals Manufacturing Process & Production OTC
Drug Research Drug Delivery Drug Discovery & Development
Contract Research & Services Clinical Trials Contract Research Contract Services
Automation IT & Software Laboratory Instrumentation
Inward Investment Packaging Regulatory Affairs

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z